Hara T, Tamai H, Mukuta T, Fukata S, Kuma K
Department of Psychosomatic Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Clin Endocrinol (Oxf). 1992 Jan;36(1):69-74. doi: 10.1111/j.1365-2265.1992.tb02904.x.
We investigated the association between thyroid function and the biological activities of thyroid stimulating antibodies (TSAb) and thyroid stimulation blocking antibodies (TSBAb) in patients with post-partum hypothyroidism.
A prospective study.
We studied 25 patients with post-partum hypothyroidism who visited our thyroid clinic during the period from 1985 to 1990.
We measured TSH binding inhibitory immunoglobulin (TBII) and TSAb activity at the initial presentation of each of the 25 patients. Women found to have elevated TSAb activity were followed up. Upon finding negative TSAb activity along with positive TBII activity in the serum at the initial presentation, we measured TSBAb activity. Women found to have elevated levels of TSBAb at the initial presentation were also followed up.
Elevated TBII activity was found in six of the 25 patients, as was high TSAb activity (205-2651%, normal 55.0-145.0%) in five of these six and in one other patient at the initial presentation. Markedly elevated TSBAb activity (89%) was found in one TBII positive patient. We were able to follow up serially five TSAb positive patients and the TSBAb positive patient over periods ranging from 11.5 to 26.5 months post-partum. The maximal value of TSAb activity was observed at the initial presentation in all TSAb positive patients, following which the activities gradually decreased. One of these patients developed Graves' hyperthyroidism associated with high TSAb activity (1223%) at 10.5 months post-partum. One of the other patients was restored to euthyroid with elevated TSAb activity (279%), but thereafter developed hypothyroidism in conjunction with the disappearance of TSAb activity at 26.5 months post-partum. In the other two patients, normalization of thyroid function was observed with elevated TSAb activity. Thereafter, thyroid function remained within the normal range even with the disappearance of TSAb activity. In the other patient, normalization of thyroid function was observed at 11.5 months post-partum, 3 months after the disappearance of TSAb activity. In the TSBAb positive patient, TSBAb activity decreased to 21% by 17.5 months post-partum associated with normalization of thyroid function.
The present study demonstrates the presence of elevated levels of TSAb activity in some patients with post-partum hypothyroidism. In these patients, Graves' hyperthyroidism may be induced by TSAb activity, and hypothyroidism may reoccur with the disappearance of the TSAb activity. Furthermore, post-partum hypothyroidism may be due to increased TSBAb activity in some patients.
我们研究了产后甲状腺功能减退患者甲状腺功能与促甲状腺素刺激抗体(TSAb)及促甲状腺素刺激阻断抗体(TSBAb)生物活性之间的关联。
一项前瞻性研究。
我们研究了1985年至1990年间就诊于我们甲状腺诊所的25例产后甲状腺功能减退患者。
我们在25例患者首次就诊时测量了促甲状腺激素结合抑制性免疫球蛋白(TBII)和TSAb活性。发现TSAb活性升高的女性进行了随访。在首次就诊时发现血清中TSAb活性为阴性且TBII活性为阳性时,我们测量了TSBAb活性。首次就诊时发现TSBAb水平升高的女性也进行了随访。
25例患者中有6例TBII活性升高,这6例中的5例以及另外1例患者在首次就诊时TSAb活性也很高(205 - 2651%,正常为55.0 - 145.0%)。1例TBII阳性患者TSBAb活性显著升高(89%)。我们能够对5例TSAb阳性患者和1例TSBAb阳性患者在产后11.5至26.5个月期间进行连续随访。所有TSAb阳性患者在首次就诊时观察到TSAb活性的最大值,此后活性逐渐下降。其中1例患者在产后10.5个月发生了与高TSAb活性(1223%)相关的格雷夫斯甲亢。另1例患者在TSAb活性升高(279%)的情况下恢复为甲状腺功能正常,但此后在产后26.5个月随着TSAb活性消失而发生甲状腺功能减退。在另外2例患者中,观察到甲状腺功能在TSAb活性升高的情况下恢复正常。此后,即使TSAb活性消失,甲状腺功能仍保持在正常范围内。在另1例患者中,产后11.5个月甲状腺功能恢复正常,此时距TSAb活性消失已3个月。在TSBAb阳性患者中,产后17.5个月时TSBAb活性降至21%,同时甲状腺功能恢复正常。
本研究表明部分产后甲状腺功能减退患者存在TSAb活性水平升高。在这些患者中,TSAb活性可能诱发格雷夫斯甲亢,且随着TSAb活性消失可能再次出现甲状腺功能减退。此外,部分患者产后甲状腺功能减退可能是由于TSBAb活性增加所致。